Videos | Heart Valve Technology

Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, explains the current state of ...

Home November 07, 2017
Home
News | Heart Valve Technology

November 7, 2017 โ€” Medtronic plc recently presented positive data for its self-expanding Intrepid transcatheter mitral ...

Home November 07, 2017
Home
News | Heart Valve Technology

http://www.tctconference.comA new study has found that a pioneering device to repair heart valves is safe and effective, and can reduce the invasiveness and side effects of conventional mitral valve surgery. The Harpoon Mitral Valve Repair System (H-MVRS), an image-guided device based on technology developed at the University of Maryland School of Medicine (UMSOM), is deployed through a small opening between the ribs, and repairs the heart while it continues to beat. The research was presented at the Transcatheter Cardiovascular Therapeutics (TCT 2017) symposium, Oct. 29-Nov. 2 in Denver, and simultaneously published in the Journal of the American College of Cardiology (JACC).

Home November 07, 2017
Home
Acutus dipole density EP mapping for ablation procedures.
Feature | Atrial Fibrillation

November 7, 2017 โ€” Here is an aggregated list of articles detailing the latest clinical data and new device technology ...

Home November 07, 2017
Home
News | Dave Fornell

November 6, 2017 โ€” In the Hybrid REvascularization Versus Standards (HREVS) study that evaluated three different ...

Home November 06, 2017
Home
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab

November 6, 2017 โ€“ Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found no ...

Home November 06, 2017
Home
Technology | Advanced Visualization

November 6, 2017 โ€” TeraRecton announced the launch of version 4.4.13 of its iNtuition advanced visualization platform ...

Home November 06, 2017
Home
News | Heart Valve Technology

November 6, 2017 โ€” One year follow-up data from the SCOUT I Early Feasibility Study for the Mitralign Trialign System ...

Home November 06, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

November 6, 2017 โ€” The first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months in ...

Home November 06, 2017
Home
News | FFR Technologies

November 6, 2017 โ€” Three-year data from the FAME 2 study show patients with coronary artery disease who underwent a ...

Home November 06, 2017
Home
News | Stents Drug Eluting

November 6, 2017 โ€” Elderly patients undergoing percutaneous coronary intervention (PCI) often receive bare-metal stents ...

Home November 06, 2017
Home
News | Cardiac Imaging

November 6, 2017 โ€“ The Centers for Medicare & Medicaid Services (CMS) has finalized a New Technology Ambulatory Payment ...

Home November 06, 2017
Home
News | Stents Drug Eluting

November 3, 2017 โ€” Biotronik's Orsiro drug-eluting stent (DES) demonstrated high long-term safety and clinical ...

Home November 03, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

November 3, 2017 โ€” A ten-year decline in the blood cholesterol of heart attack patients in Malaysia suggests statins are ...

Home November 03, 2017
Home
The Abbott/St. Jude Confirm RX implantable cardiac monitor (ICM) is the first ICM that is compatible with patients' smartphones to eliminate the need for a bedside base unit monitor to transfer data to physicians. Its FDA clearance was in October 2017.
Feature | Dave Fornell

November 3, 2017 โ€” Here is the list of the most popular articles and videos on the Diagnostic and Interventional ...

Home November 03, 2017
Home
Subscribe Now